GlaxoSmithKline (GSK) saw its shares jump more than 6% after the pharmaceutical giant announced a settlement of up to $2.2 billion (€2.01bn) to resolve tens of thousands of lawsuits in the US related to its discontinued heartburn medication, Zantac. The lawsuits alleged that the drug, which was pulled from the…
General Motors Co (NYSE: GM) is set to host its first investor day since November 2022, and investors are…
Remy Cointreau’s stock took a sharp hit, falling nearly 8.5% on Tuesday after China announced new anti-dumping tariffs on…
China’s aggressive lithium production strategy is significantly disrupting the global market, as the country floods it with this critical…
Kering, the parent company of Gucci, has appointed Stefano Cantino as the new CEO of its flagship brand at…
Palantir Technologies Inc (NYSE: PLTR) is set to disrupt the dominance of big tech, including Amazon, Microsoft, and Google,…
The Nifty 50 index rose for the second consecutive day after the Reserve Bank of India (RBI) delivered its…
The enigma of Bitcoin’s creator, Satoshi Nakamoto, has baffled the world for years. With billions of dollars and the…
The US Justice Department is weighing unprecedented action against Google as it contemplates a potential breakup of the tech…